Member Directory

F-star is a clinical-stage biopharmaceutical company developing bispecific antibody immuno-oncology products selected for their potential to transform the treatment of cancer. Through the application of its highly efficient Modular Antibody Technology™ platform, F-star is the only biotechnology company able to create bispecific antibodies, where the second binding site is in the constant Fc region of an antibody, offering unprecedented ease in the discovery, development and manufacturing of bispecific antibody products. The strength of the technology and programmes has been leveraged through partnerships with leading biopharmaceutical companies including, AbbVie, Bristol-Myers Squibb, Merck Serono and Boehringer Ingelheim.. . For more information visit

F.INSTITUTE, a full service finance boutique for the life sciences, pharma, biotech, deep tech and new energy sector, has recently expanded its portfolio of bookkeeping, tax, and CFO services for growing businesses in the UK market.

When it comes to financial services and capital advisory, F.INSTITUTE supports the growth ambitions of ventures in the fields of life sciences, food tech, deep tech, and clean tech. On your journey to success, you need a true partner. One that helps you from start to finish. That understands your business. That knows the drill and has been there before. We are that partner. We deliver.

We work for clients in life sciences, food tech, deep tech and clean tech. We are fully dedicated to the early-stage scene and welcome promising young startups and scaleups to take advantage of our affordable financial services packages. As your company grows, so does our involvement. No other full-service finance company is as embedded in your sector as we are.

Our Financial Management Services include:
• accounting
• annual report
• taxes
• dedicated finance expert
• custom chart of accounts
• R&D tax credit administration
• financial modelling w/6 years forecast including: R&D, staffing, SG&A, working capital and capex & finance
• monthly reporting
• actual vs. budget variance analysis
• management & board reporting extended Quarterly Report
• quarterly rolling forecasts
• 8 hours of CFO services

Besides Financial Management Services we also offer support and guidance across all facets of your business, so you can focus on the product. Using our Capital Advisory services means that you don’t have to hire an expensive CFO yourself, while you benefit from our expert staff.

Our Capital Advisory Services include:
• CFO Support Services
• Funding | Capital Services
• M&A | Licensing
• Valuation
• Investor Readiness

Like to know more? See our website:
Or visit us at St. John’s Innovation Centre, St. Johns Innovation Park Cowley Road, Cambridge CB4 0WS, UK.
Or call: +44 7780 774 329

Fish & Richardson is a leading global intellectual property (IP) law firm practicing in the areas of patent law, intellectual property and commercial litigation.

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of nearly $11 billion, we have approximately 37,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options.

Established in 2001, Fusion Antibodies is a Collaborative Research Organisation (CRO) with its headquarters in Northern Ireland. We are world leaders in antibody development services specializing in the discovery, engineering and supply of pre-clinical biologics to clinical Cell Line Development.
We have guided hundreds of projects through critical pre-clinical stages, repeatedly proving our expertise as we strive to bring about a positive change in the healthcare industry.
Our approach to engineering and optimization is often to harness the power of the natural somatic hypermutation space. Fusion offers flexibility and agility while delivering clinical candidates focusing on developability, manufacturability and function.
Fusion has developed a number of unique, proprietary technology platforms. Our suite of development capabilities include:
• Antibody humanization (CDRx™)
• Affinity maturation (RAMP™)
• Protein engineering
• Discovery (mouse hybridoma and rabbit B cell approaches)
• Protein production – CHO and other mammalian systems
• Cell Line Development – cGMP ready mammalian cell lines (up to 8 g/L)
• Expert scientific & technical advisory services
• Bespoke & collaborative large-scale research and development programs

Watch our Member Showcase video here